Back
Lyell Immunopharma 10K Form
Sell
38
LYEL
Lyell Immunopharma
Last Price:
1.23
Seasonality Move:
-24.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LYEL News And Ratings
See the #1 stock for the next 7 days that we like better than LYEL
LYEL Financial Statistics
Sales & Book Value
| Annual Sales: | $130K |
|---|---|
| Cash Flow: | $-38.43M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.21 |
| Price / Book: | 0.58 |
Profitability
| EPS (TTM): | -0.82000 |
|---|---|
| Net Income (TTM): | $-210.26M |
| Gross Margin: | -- |
| Return on Equity: | -32.26% |
| Return on Assets: | -28.19% |
Lyell Immunopharma Earnings Forecast
Key Lyell Immunopharma Financial Ratios
- The Research & Development expenses have been 140,726.92% of Revenue.
- The Net Earning history of LYEL is -180,486.15% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Lyell Immunopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LYEL |
| Website: | lyell.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 16.19 |
| Quick Ratio: | 15.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LYEL Technical Analysis vs Fundamental Analysis
Sell
38
Lyell Immunopharma (LYEL)
is a Sell
Is Lyell Immunopharma a Buy or a Sell?
-
Lyell Immunopharma stock is rated a Sell
The current Lyell Immunopharma [LYEL] share price is $1.28. The Score for LYEL is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.